USANA Health Sciences, Inc. (FRA:USJ)

USANA Health Sciences Statistics

Total Valuation

FRA:USJ has a market cap or net worth of EUR 336.25 million. The enterprise value is 258.83 million.

Market Cap	336.25M
Enterprise Value	258.83M

Important Dates

The last earnings date was Tuesday, February 17, 2026.

Earnings Date	Feb 17, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	18.28M
Shares Outstanding	n/a
Shares Change (YoY)	-3.07%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	9.53M

Valuation Ratios

The trailing PE ratio is 36.70 and the forward PE ratio is 10.83.

PE Ratio	36.70
Forward PE	10.83
PS Ratio	0.43
PB Ratio	0.67
P/TBV Ratio	1.51
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	28.25
EV / Sales	0.33
EV / EBITDA	3.68
EV / EBIT	6.00
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.24, with a Debt / Equity ratio of 0.02.

Current Ratio	2.24
Quick Ratio	1.23
Debt / Equity	0.02
Debt / EBITDA	0.17
Debt / FCF	n/a
Interest Coverage	60.41

Financial Efficiency

Return on equity (ROE) is 1.96% and return on invested capital (ROIC) is 3.15%.

Return on Equity (ROE)	1.96%
Return on Assets (ROA)	4.26%
Return on Invested Capital (ROIC)	3.15%
Return on Capital Employed (ROCE)	8.28%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	463,390
Profits Per Employee	5,389
Employee Count	1,700
Asset Turnover	1.24
Inventory Turnover	2.33

Taxes

In the past 12 months, FRA:USJ has paid 25.58 million in taxes.

Income Tax	25.58M
Effective Tax Rate	72.36%

Stock Price Statistics

The stock price has decreased by -39.12% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-39.12%
50-Day Moving Average	17.14
200-Day Moving Average	21.69
Relative Strength Index (RSI)	55.35
Average Volume (20 Days)	6

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.57

Income Statement

In the last 12 months, FRA:USJ had revenue of EUR 787.76 million and earned 9.16 million in profits. Earnings per share was 0.49.

Revenue	787.76M
Gross Profit	616.76M
Operating Income	43.30M
Pretax Income	35.36M
Net Income	9.16M
EBITDA	70.55M
EBIT	43.30M
Earnings Per Share (EPS)	0.49

Balance Sheet

The company has 134.84 million in cash and 11.92 million in debt, with a net cash position of 122.93 million.

Cash & Cash Equivalents	134.84M
Total Debt	11.92M
Net Cash	122.93M
Net Cash Per Share	n/a
Equity (Book Value)	499.15M
Book Value Per Share	24.80
Working Capital	136.09M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 78.29%, with operating and profit margins of 5.50% and 1.16%.

Gross Margin	78.29%
Operating Margin	5.50%
Pretax Margin	4.49%
Profit Margin	1.16%
EBITDA Margin	8.96%
EBIT Margin	5.50%
FCF Margin	n/a

Dividends & Yields

FRA:USJ does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	3.07%
Shareholder Yield	3.07%
Earnings Yield	2.72%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on November 23, 2016. It was a forward split with a ratio of 2.

Last Split Date	Nov 23, 2016
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	4